DA1 receptor-mediated renin release from isolated rat glomeruli.

The present study was performed in order to examine the effects of dopamine (DA) on renin release and to clarify which subtype of DA receptor, DA1 or DA2 contributes to renin release. Male Wistar rats aged seven weeks were used. Glomeruli were isolated by the modified Beierwaltes' sieving method and were transferred to a sealed chamber and superfused with Krebs-Ringer solution. In the first experiment, the changes in renin release induced by DA and the effects of a non-selective DA antagonist, haloperidol and a beta antagonist, propranolol on DA-induced renin release were examined. In the second experiment, the effect of a DA2 receptors antagonist, spiperone and of a DA1 receptor antagonist, SCH-23390 on renin release were investigated. Basal levels of renin release were 2.46 +/- 0.36 ng ATI/h/10(4) glomeruli (mean +/- SEM). DA caused a dose-dependent increase in renin release. The renin release induced by DA was inhibited by haloperidol but not by propranolol. The maximum level of renin release induced by 10(-5)M DA was 4.13 +/- 0.63 ng ATI/h/10(4) glomeruli. SCH-23390 at 10(-5)M caused significant suppression of DA-induced renin (p < 0.05). In contrast, 10(-5)M spiperone failed to suppress DA-induced renin release. These results suggest that DA induced renin release from isolated glomeruli through the DA1 receptors.

[1]  J. Nadler,et al.  Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans. , 1990, American journal of hypertension.

[2]  I. Nishio,et al.  Contribution of calmodulin and protein kinase C to renin release in spontaneously hypertensive rats. , 1990, American journal of hypertension.

[3]  I. Nishio,et al.  [Contribution of calmodulin to renin release in spontaneously hypertensive rats]. , 1989, Nihon Jinzo Gakkai shi.

[4]  K. Lawson,et al.  Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats. , 1987, Clinical and experimental hypertension. Part A, Theory and practice.

[5]  A. Dupont,et al.  Identification and characterization of peripheral neuronal dopamine receptors in the rat. , 1987, Clinical and experimental hypertension. Part A, Theory and practice.

[6]  G. M. Drew,et al.  Subclassification of peripheral dopamine receptors. , 1987, Clinical and experimental hypertension. Part A, Theory and practice.

[7]  D. Glock,et al.  COMPLETE SEPARATION OF PERIPHERAL DA1 AND DA2 RECEPTORS BY SELECTIVE ANTAGONISTS , 1984 .

[8]  A. Barger,et al.  Effect of intrarenal administration of dopamine on renin release in conscious dogs. , 1983, The American journal of physiology.

[9]  P. Olson,et al.  Interaction of the prostaglandin and renin-angiotensin systems in isolated rat glomeruli. , 1980, The American journal of physiology.

[10]  J. Sowers,et al.  Dopaminergic Modulation of Renin Activity and Aldosterone and Prolactin Secretion in the Spontaneously Hypertensive Rat 1 , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  C. Bell,et al.  Dopamine‐containing axons supplying the arterio‐venous anastomoses of the canine paw pad , 1978, Journal of neurochemistry.

[12]  C. Bell,et al.  DOPAMINE‐CONTAINING VASOMOTOR NERVES IN THE DOG KIDNEY , 1978, Journal of neurochemistry.

[13]  M. Weinberger,et al.  The effects of dopamine on renin release in vitro. , 1977, Endocrinology.

[14]  J. Schwartz,et al.  Effect of dopamine on renin secretion in the anesthetized dog. , 1975, European journal of pharmacology.

[15]  J. Ménard,et al.  A micromethod for measurement of renin in the plasma and kidney of rats. , 1967, Canadian journal of physiology and pharmacology.